Aveanna Healthcare Holdings Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Aveanna Healthcare Holdings Inc 's ROA in the second quarter of 2026?
Aveanna Healthcare Holdings Inc achieved a return on average assets (ROA) of 13.82 % in its second quarter of 2026 a new company high.

Despite the company's net income deteriorating, Aveanna Healthcare Holdings Inc was able to improve its ROA compared to the first quarter of 2026.

However, within the Healthcare sector 69 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jul 04 2026 quarter, so far to 400, from total ROA ranking in the first quarter of 2026 at 550.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jul 04 2026) II. Quarter	(Apr 04 2026) I. Quarter	(Jan 03 2026) IV. Quarter	(Sep 27 2025) III. Quarter	(Jun 28 2025) II. Quarter
Y / Y Total Assets Change	18.94 %	21.76 %	25.6 %	14.68 %	10.85 %
Y / Y Net Income Change	49.1 %	702.1 %	512.58 %	-	94.34 %
Net Income (TTM) in million	275	261	225	75	19
Return On Assets (TTM)	13.82 %	13.73 %	12.41 %	4.41 %	1.12 %
AVAH's Total Ranking	# 400	# 550	# 1296	# 2123	# 2490
Total Assets (TTM) in million	2,106	2,022	2,012	1,810	1,771
Seq. Total Assets Change	4.17 %	0.48 %	11.15 %	2.23 %	6.64 %
Seq. Net Income Change	-3.27 %	-76.7 %	1170.99 %	-47.96 %	420.41 %

AVAH's 5 Years Annual ROA >> Back to AVAH Management Effectiveness >> Compare AVAH ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 1
Sector	# 70
Overall	# 390

Return On Assets Statistics
High	Average	Low
13.82 %	-7.05 %	-39.28 %
(Jul 04 2026)		(Apr 01 2023)

Financial Statements
Aveanna Healthcare Holdings Inc 's Assets	$ 2,106 million	AVAH's Balance sheet
Aveanna Healthcare Holdings Inc 's Income	$ 40 million	Quarterly AVAH's Income Statement
AVAH's Income by Division		See AVAH's Income by Division

Annual Return On Assets	(Jan 03 2026) FY 2026	(Dec 28 2024) FY 2024	(Dec 30 2023) FY 2023	(Dec 31 2022) FY 2022	FY
Y / Y Total Assets Change	25.6 %	3.77 %	-5.74 %	-	-
Total Assets in million	2,012	1,602	1,544	1,638	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	225	-11	-135	-662	0
Annual Return On Assets	11.18 %	-0.68 %	-8.71 %	-40.42 %	-

AVAH's 5 Years Annual ROA >> Back to AVAH Management Effectiveness >> Compare AVAH ROA to its Competitors

Comment on AVAH's ROA in the fiscal year ending 2026

In the fiscal year 2026 ROA improved to 11.18 % compared to prior year, due to annual net income growth of % to $225.03 million, while value of Aveanna Healthcare Holdings Inc 's overall assets grew just by 25.6 % to $2,012.38 million, compared to $2,012.38 a year before.

More Return On Assets Ratios
AVAH's' Return on Assets at Yahoo Finance
Healthcare Facilities Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
AVAH's Roa Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for AVAH's Competitors
Subscribers only: Roa for Aveanna Healthcare Holdings Inc 's Suppliers
Subscribers only: Return On Assets for AVAH's Customers

You may also want to know
AVAH's Roi	AVAH's Inventory Turnover Ratio	AVAH's Growth Rates	AVAH's Dividend Comparisons
	AVAH's Profitability Ratios	AVAH's Asset Turnover Ratio	AVAH's Dividend Growth
AVAH's Roe	AVAH's Valuation Ratios	AVAH's Financial Strength Ratios	AVAH's Dividend Payout Ratio

Companies with similar Return On Assets at Jul 04 2026, within Healthcare Sector	ROA
Liquidia Corporation	36.30 %
Ironwood Pharmaceuticals inc	34.34 %
Idexx Laboratories Inc	33.61 %
Tg Therapeutics Inc	33.59 %
Meiragtx Holdings Plc	29.37 %
Indivior Pharmaceuticals Inc	28.21 %
Qhslab Inc	27.12 %
Adma Biologics Inc	26.58 %
Mettler toledo International Inc	24.86 %
Medpace Holdings Inc	24.84 %
Caredx Inc	24.81 %
Acadia Pharmaceuticals Inc	24.38 %
Eli Lilly And Company	21.97 %
Innoviva Inc	21.64 %
Vaxart Inc	20.85 %
Zevra Therapeutics Inc	20.39 %
Iradimed Corporation	20.36 %
Protalix Biotherapeutics inc	20.09 %
Pro dex Inc	19.87 %
Electromed Inc	19.39 %
United Therapeutics Corporation	17.98 %
Resmed Inc	17.80 %
Krystal Biotech Inc	17.65 %
Chemed Corporation	17.52 %
Zoetis Inc	17.19 %
Vertex Pharmaceuticals Inc	16.88 %
Halozyme Therapeutics Inc	16.55 %
Alnylam Pharmaceuticals Inc	15.76 %
Intuitive Surgical Inc	15.63 %
Healthcare Services Group Inc	15.21 %

Date modified: 2026-09-12T06:24:53+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.